Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
Abroad (travel likely)RecruitingPHASE2
Conditions
Cushing Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Shlomo Melmed, MD)Ning-Ai Liu, MD (Sub-investigator)
Study leads
Shlomo Melmed, MD
Principal Investigator
Cedars-Sinai Medical Center
Ning-Ai Liu, MD, PhD
Study Director
Cedars-Sinai Medical Center